Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm	Recruiting	Phase 2 / Phase 3	2026-03-19		NCT05179889

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Boryung Pharmaceutical Co., Ltd	32
Chungnam National University Hospital	34

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Chungnam National University Hospital	Daejeon	South Korea	1

Clinical trials